G
389030
vs
K
KOSPI 200
Over the past 12 months, Geninus Inc has significantly outperformed KOSPI 200, delivering a return of +350% compared to the KOSPI 200's +134% growth.
Stocks Performance
389030 vs KOSPI 200
Performance Gap
389030 vs KOSPI 200
Performance By Year
389030 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Geninus Inc
Glance View
GENINUS, Inc. is engaged in the research and development of NGS (Next Generation Sequencing)-based genome analysis technology, development and manufacturing of genome analysis solutions. The company is headquartered in Seoul, Seoul. The company went IPO on 2021-11-08. The firm is engaged in the provision of single cell analysis services, genetic testing for disease prediction for the public, cancer genome analysis solutions based on tissue biopsy and other services. The company is also engaged personal genetic testing, software development, rental business and others.
